Literature DB >> 20207783

Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery.

Emilio Portaccio1, Benedetta Goretti, Valentina Zipoli, Alfonso Iudice, Dario Della Pina, Gian Michele Malentacchi, Simonetta Sabatini, Pasquale Annunziata, Mario Falcini, Monica Mazzoni, Maria Pia Amato.   

Abstract

The role of cognitive impairment in multiple sclerosis is now widely recognized. However, there is a dearth of research on variability and practice effects of neuropsychological measures when repeated over time. The objective was to assess reliability and practice effects for Rao's Brief Repeatable Battery of neurophysiological tests and the Stroop Test, and to provide data for correction for variability and practice effects in serial assessments.In 54 healthy controls (34 women, mean age 38.3 +/- 9.1 years, mean education 12.9 +/- 3.3 years), the Brief Repeatable Battery and Stroop Test were administered 3 times with an 18-month interval. Reliability was assessed by intraclass correlation coefficient and practice effects by an analysis of variance with Bonferroni's correction for repeated measures. Test-retest reliability was from adequate to good on the Symbol Digit Modalities Test, the Stroop Test, and the Paced Auditory Serial Addition Test. The great majority of tests showed at least a moderate practice effects. Data for calculation of an individual's change in cognitive performance for each test of the Brief Repeatable Battery and the Stroop Test were provided. Our results provide relevant information for planning and interpreting longitudinal studies on cognition and cognitive rehabilitation in multiple sclerosis.

Entities:  

Mesh:

Year:  2010        PMID: 20207783     DOI: 10.1177/1352458510362818

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  17 in total

Review 1.  Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods.

Authors:  Kevin Duff
Journal:  Arch Clin Neuropsychol       Date:  2012-02-29       Impact factor: 2.813

2.  Effects of nicotine on response inhibition and interference control.

Authors:  Ulrich Ettinger; Eliana Faiola; Anna-Maria Kasparbauer; Nadine Petrovsky; Raymond C K Chan; Roman Liepelt; Veena Kumari
Journal:  Psychopharmacology (Berl)       Date:  2017-02-01       Impact factor: 4.530

3.  Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test.

Authors:  Suzanne L Barker-Collo; Suzanne C Purdy
Journal:  Int J MS Care       Date:  2013

4.  Pharmacokinetic-Pharmacodynamic Modeling of Intravenous and Oral Topiramate and Its Effect on the Symbol-Digit Modalities Test in Adult Healthy Volunteers.

Authors:  Chay Ngee Lim; Angela K Birnbaum; Richard C Brundage; Ilo E Leppik; James C Cloyd; Annie Clark; Susan E Marino
Journal:  J Clin Pharmacol       Date:  2015-12-21       Impact factor: 3.126

5.  The Effects of Cognitive Rehabilitation on Relapsing Remitting Multiple Sclerosis Patients.

Authors:  İlknur Güçlü Altun; Dursun Kirbaş; Deniz Utku Altun; Aysun Soysal; Pakize Nevin Sütlaş; Demet Yandim Kuşçu; Neslihan Behrem Gayir; Ekim Arslan; Barış Topçular
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

6.  The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.

Authors:  D Obradovic; M Petrovic; I Antanasijevic; J Marinkovic; T Stojanovic; S Obradovic
Journal:  Neurol Sci       Date:  2012-05-03       Impact factor: 3.307

Review 7.  Risk factors for and management of cognitive dysfunction in multiple sclerosis.

Authors:  Ralph H B Benedict; Robert Zivadinov
Journal:  Nat Rev Neurol       Date:  2011-05-10       Impact factor: 42.937

8.  Regression-based formulas for predicting change in memory test scores in healthy older adults: Comparing use of raw versus standardized scores.

Authors:  January Durant; Kevin Duff; Justin B Miller
Journal:  J Clin Exp Neuropsychol       Date:  2019-02-05       Impact factor: 2.475

Review 9.  Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).

Authors:  D W Langdon; M P Amato; J Boringa; B Brochet; F Foley; S Fredrikson; P Hämäläinen; H-P Hartung; L Krupp; I K Penner; A T Reder; R H B Benedict
Journal:  Mult Scler       Date:  2011-12-21       Impact factor: 6.312

10.  Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.

Authors:  Pietro Iaffaldano; Rosa Gemma Viterbo; Damiano Paolicelli; Guglielmo Lucchese; Emilio Portaccio; Benedetta Goretti; Vita Direnzo; Mariangela D'Onghia; Stefano Zoccolella; Maria Pia Amato; Maria Trojano
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.